A Survey About Hot Flashes in Women Going Through the Menopause

What this trial studies

This study is an online survey of women in and around menopause with moderate to severe hot flashes. Menopause, a normal part of life, is a time after a woman's last period. Hot flashes often occur during menopause. They can disrupt a woman's daily life.

Conditions in scope

• Menopause
• Vasomotor Symptoms

Interventions

• No Intervention (Other) — This is a cross-sectional non-product related survey including peri- and post-menopausal women with moderate to severe VMS associated with menopause.

Who can join

Women only · Ages 40 Years to 65 Years

Inclusion criteria

• \- Post-menopausal women
• Women currently experiencing, or have experienced in the last month, moderate to severe VMS symptoms (i.e. minimum of 1 moderate to severe hot flushes per day over the last month)
• Peri-menopausal and post-menopausal women

Exclusion criteria

• Women with current breast cancer treatment
• Women treated with anti-estrogens, aromatase inhibitors or Gonadotropin-releasing hormone (GnRH) agonists/antagonists for cancer or any other medical condition.
• Additional exclusion criterion for secondary outcome measures will be:
• \- Mild VMS symptoms only

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

Status & timeline

• Overall status: Completed
• Study type: Observational
• Phase: N/A
• Start date: 2021-11-04
• Primary completion: 2022-01-17
• Last update posted: 2024-10-26
• First posted: 2021-10-19

Sponsor & contact

Lead sponsor: Astellas Pharma Europe Ltd. (Industry)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

• Prevalence of moderate to severe vasomotor symptoms (VMS) in post-menopausal women (1 day (once through survey))
  Prevalence of moderate to severe VMS in post-menopausal women. Post-menopause is defined as at least 12 consecutive months without a period. Moderate VMS associated with menopause symptoms is defined as sensations of heat with sweating but being able to continue activities. Severe VMS associated with menopause is defined as feelings of intense heat with sweating causing cessation of activities. The…

Related ClearedRx care

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.